日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

High pretreatment peripheral blood T-cell receptor clonality as a predictor of prolonged response in immune thrombocytopenia

治疗前外周血T细胞受体克隆性高可预测免疫性血小板减少症的长期疗效

Schmidt-Barbo, Paul; Schultheiss, Christoph; Jauch, Annaïse J; Simnica, Donjetë; Silling, Gerda; Hänel, Mathias; Chromik, Jörg; Stauch, Thomas; Trautmann-Grill, Karolin; Repp, Roland; Schulte, Clemens; Fleischmann, Bastian; Welslau, Manfred; Stauch, Martina; Quiering, Claudia; Richter, Frank; Tesanovic, Tamara; Jahn, Sabine; Holbro, Andreas; Passweg, Jakob R; Matzdorff, Axel; Rummel, Mathias; Meyer, Oliver; Nimmerjahn, Falk; Binder, Mascha

Deciphering the genetic basis of immune thrombocytopenia: current evidence for genetic predisposition in adult ITP

揭示免疫性血小板减少症的遗传基础:成人ITP遗传易感性的最新证据

Georgi, Julia-Annabell; Middeke, Jan Moritz; Bornhäuser, Martin; Matzdorff, Axel; Trautmann-Grill, Karolin

The EHA Research Roadmap: Platelet Disorders

欧洲血液学协会研究路线图:血小板疾病

Balduini, Carlo; Freson, Kathleen; Greinacher, Andreas; Gresele, Paolo; Kühne, Thomas; Scully, Marie; Bakchoul, Tamam; Coppo, Paul; Dovc Drnovsek, Tadeja; Godeau, Bertrand; Gruel, Yves; Rao, A Koneti; Kremer Hovinga, Johanna A; Makris, Michael; Matzdorff, Axel; Mumford, Andrew; Pecci, Alessandro; Raslova, Hana; Rivera, José; Roberts, Irene; Scharf, Rüdiger E; Semple, John W; Van Geet, Christel

Primary Thromboprophylaxis in Patients with Malignancies: Daily Practice Recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO), the Society of Thrombosis and Hemostasis Research (GTH), and the Austrian Society of Hematology and Oncology (ÖGHO)

恶性肿瘤患者的一级血栓预防:德国血液学和肿瘤内科学会 (DGHO)、血栓和止血研究学会 (GTH) 以及奥地利血液学和肿瘤学会 (ÖGHO) 止血工作组的日常实践建议

Kirschner, Martin; do Ó Hartmann, Nicole; Parmentier, Stefani; Hart, Christina; Henze, Larissa; Bisping, Guido; Griesshammer, Martin; Langer, Florian; Pabinger-Fasching, Ingrid; Matzdorff, Axel; Riess, Hanno; Koschmieder, Steffen

Unanswered Questions

未解答的问题

Matzdorff, Axel

Non-vitamin K Antagonist Oral Anticoagulants (NOAC) as an Alternative Treatment Option in Tumor-Related Venous Thromboembolism

非维生素K拮抗剂口服抗凝剂(NOAC)作为肿瘤相关静脉血栓栓塞症的替代治疗选择

Beyer-Westendorf, Jan; Klamroth, Robert; Kreher, Stephan; Langer, Florian; Matzdorff, Axel; Riess, Hanno

Salvage therapy with high-dose cytarabine and mitoxantrone in combination with all-trans retinoic acid and gemtuzumab ozogamicin in acute myeloid leukemia refractory to first induction therapy

对于一线诱导治疗无效的急性髓系白血病,挽救治疗方案为:高剂量阿糖胞苷和米托蒽醌联合全反式维甲酸和吉妥珠单抗。

Hütter-Krönke, Marie-Luise; Benner, Axel; Döhner, Konstanze; Krauter, Jürgen; Weber, Daniela; Moessner, Margit; Köhne, Claus-Henning; Horst, Heinz A; Schmidt-Wolf, Ingo G H; Rummel, Mathias; Götze, Katharina; Koller, Elisabeth; Petzer, Andreas L; Salwender, Hans; Fiedler, Walter; Kirchen, Heinz; Haase, Detlef; Kremers, Stephan; Theobald, Matthias; Matzdorff, Axel C; Ganser, Arnold; Döhner, Hartmut; Schlenk, Richard F

Assessing patients' anticoagulation preferences for the treatment of cancer-associated thrombosis using conjoint methodology

采用联合分析法评估患者对癌症相关血栓治疗的抗凝偏好

Noble, Simon; Matzdorff, Axel; Maraveyas, Anthony; Holm, Majbrit V; Pisa, Giovanni